John Wiley and Sons: Study Shows Opioid Use Among U.S. Patients With Knee Osteoarthritis Costs 14 Billion Dollars in Societal Costs
February 26, 2021
February 26, 2021
HOBOKEN, New Jersey, Feb. 26 -- John Wiley and Sons issued the following news release:
Although guidelines do not recommend use of opioids to manage pain for individuals with knee osteoarthritis, a recent study published early online in Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Professionals, estimates that 858,000 Americans use opioids such as tramadol and oxycodone for their knee pain, equating to . . .
Although guidelines do not recommend use of opioids to manage pain for individuals with knee osteoarthritis, a recent study published early online in Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Professionals, estimates that 858,000 Americans use opioids such as tramadol and oxycodone for their knee pain, equating to . . .